Cargando…
Serum microRNAs as potential new biomarkers for cisplatin resistance in gastric cancer patients
BACKGROUND: microRNAs (miRNAs) have been studied for their role in the early detection of several diseases. However, there is no current information on the systematic screening of serum-derived cisplatin resistance biomarkers in gastric cancer (GC). METHODS: Cisplatin-resistant GC cell lines were sc...
Autores principales: | Jin, Lei, Zhang, Nan, Zhang, Qian, Ding, Guoqian, Yang, Zhenghan, Zhang, Zhongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164432/ https://www.ncbi.nlm.nih.gov/pubmed/32328349 http://dx.doi.org/10.7717/peerj.8943 |
Ejemplares similares
-
Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy
por: Wang, Nannan, et al.
Publicado: (2015) -
Targeting Oncogenic miR-181a-2-3p Inhibits Growth and Suppresses Cisplatin Resistance of Gastric Cancer
por: Jin, Lei, et al.
Publicado: (2021) -
Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer
por: Wang, M, et al.
Publicado: (2014) -
MicroRNAs are exported from malignant cells in customized particles
por: Palma, Jaime, et al.
Publicado: (2012) -
Circulating microRNAs in plasma of patients with gastric cancers
por: Tsujiura, M, et al.
Publicado: (2010)